Owner Sunesis Pharmaceuticals, Inc

Inventors Prescott, John C; Braisted, Andrew

Agent Griffith Hack

Pub. Number AU-B-2003228345

PCT Number PCT/US03/08725

PCT Pub. Number WO2003/081210

Priority 60/366,892 21.03.02 US

Filing date 20 March 2003

Wipo publication date 8 October 2003

Acceptance publication date 5 February 2009

C12Q 1/00 (2006.01) Measuring or testing processes involving enzymes or micro-organisms

C07K 1/00 (2006.01) General processes for the preparation of peptides

C12N 9/00 (2006.01) Enzymes, e.g. ligases (6.)

C12N 9/12 (2006.01) Enzymes, e.g. ligases (6.) - transferring phosphorus containing groups, e.g. kinases (2.7)

C12N 15/09 (2006.01) Mutation or genetic engineering - Recombinant DNA-technology

C12N 15/74 (2006.01) Mutation or genetic engineering - Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora

C12Q 1/48 (2006.01) Measuring or testing processes involving enzymes or micro-organisms - involving transferase

C12Q 1/68 (2006.01) Measuring or testing processes involving enzymes or micro-organisms - involving nucleic acids

C40B 30/04 (2006.01) Methods of screening libraries - by measuring the ability to specifically bind a target molecule, e.g. antibody-antigen binding, receptor-ligand binding

G01N 33/566 (2006.01) Investigating or analysing materials by specific methods not covered by groups - using specific carrier or receptor proteins as ligand binding reagent

G01N 33/68 (2006.01) Investigating or analysing materials by specific methods not covered by groups - involving proteins, peptides or amino acids